Stocks
Boston Scientific (BSX) EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 2 741 | 3 620 | 3 453 | 3 938 | 3 733 | 4 763 | ||
| Changes by years, y/y, % | +9% | +32% | -5% | +14% | -5% | +19.8% | |||
Boston Scientific. EBITDA US GAAP, bln rub
Boston Scientific. EBITDA US GAAP, changes, %
Boston Scientific. EBITDA US GAAP, sum by quarters, bln rub
Boston Scientific (BSX) EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 1 217 | 1 367 | 1 368 | 956.0 | 1 072 | 4 763 | |
| Changes by years, y/y, % | +24% | +68% | +29% | -11% | -12% | |||
| Changes by quarters, q/q, % | +14% | +12% | +0% | -30% | +12% | |||
